AMH Levels and Fertility: What Your Anti-Müllerian Hormone Test Tells You

Anti-Müllerian hormone (AMH) is one of the most informative single markers of ovarian reserve available through routine blood testing, and its measurement has become a central component of fertility assessments for anyone considering at-home insemination or assisted reproduction. Unlike FSH, which fluctuates across the menstrual cycle, AMH is produced continuously by developing follicles and can be measured on any day of the cycle. Understanding what your AMH result means — and what it does not mean — is essential for making informed decisions about your fertility timeline.

What AMH Measures and Why It Matters

AMH is secreted by granulosa cells of pre-antral and small antral follicles — follicles in the early stages of development that represent your current available ovarian reserve. Higher AMH levels reflect a larger pool of developing follicles, while lower levels reflect a diminished pool. The test is most useful as a relative measure of ovarian reserve compared to age-matched reference ranges, because absolute AMH levels decline naturally with age as follicles are continuously recruited and depleted throughout reproductive life.

AMH does not directly measure egg quality — only quantity. This distinction is clinically important because a woman with low AMH may still have high-quality eggs, and a woman with high AMH (as seen in PCOS) may have eggs with impaired developmental competence due to the underlying hormonal environment. When AMH is used alongside antral follicle count (AFC) by ultrasound, the combined assessment provides both quantity and morphological quality context that AMH alone cannot supply.

Interpreting AMH Results by Age

AMH reference ranges vary by laboratory assay and by age cohort. Using the widely cited Beckman Coulter AMH Gen II assay reference values: at age 25, the median AMH is approximately 3.2 ng/mL with a normal range of 1.5 to 8.5 ng/mL. At age 35, the median declines to approximately 1.8 ng/mL (range 0.7 to 5.0 ng/mL). At age 40, the median is approximately 0.7 ng/mL, and values below 0.5 ng/mL at this age indicate diminished reserve. Values below 1.0 ng/mL at any age under 35 warrant discussion with a reproductive endocrinologist about the advisability of egg freezing or an expedited conception timeline.

Elevated AMH (above the 97th percentile for age) is most commonly associated with polycystic ovarian syndrome, where the large number of small arrested follicles produces AMH in excess of the age-expected range. AMH above 5.0 ng/mL at any age after 30 should prompt ultrasound evaluation to assess antral follicle count and rule out PCOS if not previously diagnosed.

What Low AMH Means for At-Home Insemination

Low AMH does not preclude natural conception or at-home ICI success — it means that the window of reproductive opportunity may be shorter than average and that the urgency to attempt conception is higher. Women with low AMH often still ovulate regularly and produce fertilizable eggs; the diminished reserve reflects fewer cycles remaining rather than inability to conceive in the near term. However, response to ovulation induction medications (if used in monitored cycles) is likely to be lower, meaning fewer follicles respond per stimulated cycle.

For at-home ICI users with low AMH, the most actionable responses are: confirm ovulation is occurring each cycle using LH strip monitoring and basal body temperature charting before investing in multiple ICI cycles; consult a reproductive endocrinologist if conception has not occurred after 3 to 4 ICI cycles given the reduced timeline margin; and consider antioxidant supplementation (CoQ10, vitamin D, DHEA under medical guidance) that has emerging evidence for supporting egg quality in diminished ovarian reserve, though the evidence base for AMH improvement specifically is limited.

Testing Logistics and When to Retest

AMH can be measured on any day of the menstrual cycle and does not require fasting, making it one of the most convenient fertility hormone tests. Home AMH test kits are now available through several direct-to-consumer health platforms (Everlywell, LetsGetChecked, Mira) at costs of $80 to $150, providing a result within 5 to 7 business days. Sensitivity and specificity of these home kits using the same ELISA-based assay platforms as clinical laboratories are comparable for clinical decision-making purposes, though results should be confirmed in a clinical laboratory setting before making major fertility treatment decisions.

AMH declines at an average rate of approximately 5% to 7% per year in reproductive-age individuals, meaning annual retesting is sufficient for most users monitoring reserve over time. More frequent testing (every 3 to 6 months) is appropriate after cancer treatment, ovarian surgery, or endometrioma resection, where acute decline may occur over a shorter timeframe. A single AMH value is most meaningful in the context of a trend — a result that appears low-normal in isolation may represent a rapid decline from a previously normal baseline if historical testing exists for comparison.

For a complete at-home insemination solution, the His Fertility Boost includes everything you need for a properly timed, sterile ICI cycle.

---

Further reading across our network: IntracervicalInsemination.org · MakeAmom.com · IntracervicalInseminationKit.info · IntracervicalInseminationKit.org

---

This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making decisions about your fertility care.